Stephen Tong
University of Melbourne, Mercy Hospital for Women, VIC, Australia
- This delegate is presenting an abstract at this event.

Professor Stephen Tong is a clinician-scientist (specialist obstetrician) at The Mercy Hospital for Women and The University of Melbourne in Australia.
He is focussed on translational research. His team has taken 5-6 laboratory concepts to international clinical trials running in United Kingdom, South Africa, New Zealand and across Australia.
Working with senior researchers, he has led a translational pipeline to identify new drugs to treat preeclampsia. The pipeline begins with laboratory evaluation to discover promising candidates to treat preeclampsia. It extends to successive randomised placebo controlled clinical trials running in South Africa (where the most promising drugs found in the laboratory are evaluated).
Prof Tong’s also co-leads research programs to develop diagnostics to prevent stillbirth, new treatments for ectopic pregnancy and epidemiology studies evaluating drug safety.
He has published over 190 papers, including contributions over recent years in The Lancet, British Medical Journal, Nature Communication, Human Reproduction Update; and multiple papers in BMC Medicine, Hypertension, American Journal of Obstetrics and Gynaecology; and others.
He has received three national awards from the National Health and Medical Research Council of Australia. Over the past decade he and his team has obtained over 8 million dollars in competitive grant funding for research.
Presentations this author is a contributor to:
Statins reduce the toxin of preeclampsia soluble Flt1, and quench endothelial dysfunction in primary human tissues: a potential therapeutic for preeclampsia (#337)
5:00 PM
Fiona Brownfoot
SRB Posters - Pregnancy/Parturition/Placenta
The newly described primate and placental specific sFlt1 isoform - e15a is biologically active and antagonises VEGF (#341)
5:00 PM
Tu'uhevaha J Kaitu'u-Lino
SRB Posters - Pregnancy/Parturition/Placenta
Pyrosequencing of bacterial 16S ribosomal RNA demonstrates distinct microbiome profiles of placenta and maternal blood in women with preterm ruptured membranes who develop chorioamnionitis, compared to those who do not become infected. (#26)
10:45 AM
Owen Stock
SRB -ANZPRA Award Finalists
Proton Pump Inhibitors as a novel candidate therapeutic to treat severe preeclampsia. (#87)
10:40 AM
Natalie J Hannan
SRB - Newcastle Award for emerging research leaders
Fetal growth restriction is associated with paternal diet induced obesity (#25)
10:30 AM
Natalie K Binder
SRB -ANZPRA Award Finalists